Tandem Diabetes (TNDM) Tops Q2 EPS by 4c

Tandem Diabetes (NASDAQ: TNDM) reported Q2 EPS of ($0.44), $0.04 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $21.3 million versus the consensus estimate of $21.74 million.

For earnings history and earnings-related data on Tandem Diabetes (TNDM) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• FactSet (FDS) Tops Q3 EPS by 8c ; Offers Guidance
• RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform